INSTANT

A Prospective Randomized Multicenter Study of Flecainide Acetate Oral Inhalation Solution in Single and Repeat Dose Regimens for Acute Conversion to Sinus Rhythm in Subjects With Recent Onset of Symptomatic Paroxysmal Atrial Fibrillation

Objective

To explore the electrocardiographic effects of inhaled flecainide under two oral inhalation dosing regiments in subjects with recent onset of paroxysmal AF

Eligibility

1. Subjects with recent-onset symptomatic AF at presentation,

2. With a duration at onset of symptoms from 1 hour to 48 hours,

3. And from one of the following categories:

     a. First detected episode of paroxysmal AF

     b. Recurrent episode of paroxysmal AF

     c. Episode post-cardiac ablation for paroxysmal AF

NCT ID

NCT03539302